Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 1-deamino-8-d-arginine Vasopressin
2. 1-desamino-8-arginine Vasopressin
3. Acetate, Desmopressin
4. Adiuretin
5. Adiuretin Sd
6. Apo-desmopressin
7. Arginine Vasopressin, Deamino
8. Ddavp
9. Deamino Arginine Vasopressin
10. Desmogalen
11. Desmopressin
12. Desmopressin Monoacetate
13. Desmopressin Monoacetate, Trihydrate
14. Desmopressine Ferring
15. Desmospray
16. Desmotabs
17. Ferring, Desmopressine
18. Minirin
19. Minurin
20. Monoacetate, Desmopressin
21. Monoacetate, Trihydrate Desmopressin
22. Nocutil
23. Octim
24. Octostim
25. Trihydrate Desmopressin Monoacetate
26. Vasopressin, 1-deamino-8-d-arginine
27. Vasopressin, 1-desamino-8-arginine
28. Vasopressin, Deamino Arginine
1. Octostim
2. Minirin
3. Ddavp
4. Stimate
5. Concentraid
6. Desmopressin Acetate Anhydrous
7. Noctiva
8. 62288-83-9
9. Ddavp (needs No Refrigeration)
10. Desmospray
11. Anhydrous Desmopressin Acetate
12. Desmopressin Acetate Preservative Free
13. Desmopressin Acetate (needs No Refrigeration)
14. 1k12647sfc
15. Desmopressin Acetate Hydrate
16. Desmotabs
17. Minirine
18. Nocutil
19. Octim
20. Desmopressin Acetate Trihydrate
21. Demopressin Acetate
22. Ddavp Nasal Spray
23. Ddavp Rhinal Tube
24. Stimate Nasal Spray
25. Noqdirna
26. Presinex
27. Desmomelt
28. Unii-1k12647sfc
29. Desmopressin Acetate [usan:jan]
30. Chembl1200556
31. Dtxsid4046864
32. 16679-58-6(free Base)
33. Desmopressin Acetate [mi]
34. Stimate (needs No Refrigeration)
35. Ex-a4285
36. 1-(3-mercaptopropionic Acid)-8-d-arginine Vasopression Monoacetate
37. Bdbm50247923
38. Mfcd00133962
39. Akos025311518
40. Ccg-270644
41. Desmopressin Monoacetate Anhydrous
42. Anhydrous Desmopressin Acetate [mart.]
43. (deamino-cys1,d-arg8)-vasopressin Acetate
44. 789d983
45. Q27252517
46. 1-(3-mercaptopropionic Acid)-8-d-arginine-vasopressin Monoacetate (salt)
47. Vasopressin, 1-(3-mercaptopropanoic Acid)-8-d-arginine-, Monoacetate (salt)
48. Vasopressin,1-(3-mercaptopropanoic Acid)-8-d-arginine-,monoacetate(salt)(9ci)
Molecular Weight | 1129.3 g/mol |
---|---|
Molecular Formula | C48H68N14O14S2 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 19 |
Exact Mass | 1128.44808525 g/mol |
Monoisotopic Mass | 1128.44808525 g/mol |
Topological Polar Surface Area | 526 Ų |
Heavy Atom Count | 78 |
Formal Charge | 0 |
Complexity | 2070 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Desmopressin acetate |
Drug Label | Desmopressin Nasal Spray Solution USP, 0.01% is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. The structural formula for the active ingredient is:Mol. w... |
Active Ingredient | Desmopressin acetate |
Dosage Form | Injectable; Spray, metered; Tablet; Solution |
Route | Nasal; oral; Injection; Oral |
Strength | 0.01mg/spray; 0.004mg/ml; 0.2mg; 0.01%; 0.1mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Glenmark Generics; Teva Pharms; Hospira; Actavis Labs Fl; Apotex; Bausch And Lomb; Sun Pharm Inds; Teva Pharms Usa; Ferring |
2 of 2 | |
---|---|
Drug Name | Desmopressin acetate |
Drug Label | Desmopressin Nasal Spray Solution USP, 0.01% is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. The structural formula for the active ingredient is:Mol. w... |
Active Ingredient | Desmopressin acetate |
Dosage Form | Injectable; Spray, metered; Tablet; Solution |
Route | Nasal; oral; Injection; Oral |
Strength | 0.01mg/spray; 0.004mg/ml; 0.2mg; 0.01%; 0.1mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Glenmark Generics; Teva Pharms; Hospira; Actavis Labs Fl; Apotex; Bausch And Lomb; Sun Pharm Inds; Teva Pharms Usa; Ferring |
Antidiuretic Agents
Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS. (See all compounds classified as Antidiuretic Agents.)
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Ukraine
Brand Name : Uropres
Dosage Form : Nasal Spray
Dosage Strength : 0.1MG/ML
Packaging : 2.5ML, 5ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info :
Registration Country : Sweden
Brand Name : Desmopressin Ferring
Dosage Form : TABLET
Dosage Strength : 0.1 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Minirin/Ddavp
Dosage Form : Desmopressin 0,125Mg Spray Nasal Use
Dosage Strength : nasal spray 0.125 mg 2.5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Nocdurna
Dosage Form : Smeltetablett
Dosage Strength : 50 mcg
Packaging : Blister, endose
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Minirin
Dosage Form : Melting tablet
Dosage Strength : 240 microg
Packaging : Blisterpakning 30item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Nocdurna
Dosage Form : Melting tablet
Dosage Strength : 50 micrograms
Packaging : Endose blister pack 30 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Minirin
Dosage Form : Tablet
Dosage Strength : 0.1mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Octostim
Dosage Form : Inj L?s
Dosage Strength : 15mcg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Sweden
Brand Name : Nocutil
Dosage Form : TABLET
Dosage Strength : 0.2 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Desmopressin 2care4
Dosage Form : Nose spray, resolution
Dosage Strength : 10 mcg/dose
Packaging : Bottle of dark glass with dose pump
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Desmopressin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Desmopressin, including repackagers and relabelers. The FDA regulates Desmopressin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Desmopressin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Desmopressin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Desmopressin supplier is an individual or a company that provides Desmopressin active pharmaceutical ingredient (API) or Desmopressin finished formulations upon request. The Desmopressin suppliers may include Desmopressin API manufacturers, exporters, distributors and traders.
click here to find a list of Desmopressin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Desmopressin DMF (Drug Master File) is a document detailing the whole manufacturing process of Desmopressin active pharmaceutical ingredient (API) in detail. Different forms of Desmopressin DMFs exist exist since differing nations have different regulations, such as Desmopressin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Desmopressin DMF submitted to regulatory agencies in the US is known as a USDMF. Desmopressin USDMF includes data on Desmopressin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Desmopressin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Desmopressin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Desmopressin Drug Master File in Japan (Desmopressin JDMF) empowers Desmopressin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Desmopressin JDMF during the approval evaluation for pharmaceutical products. At the time of Desmopressin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Desmopressin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Desmopressin Drug Master File in Korea (Desmopressin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Desmopressin. The MFDS reviews the Desmopressin KDMF as part of the drug registration process and uses the information provided in the Desmopressin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Desmopressin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Desmopressin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Desmopressin suppliers with KDMF on PharmaCompass.
A Desmopressin CEP of the European Pharmacopoeia monograph is often referred to as a Desmopressin Certificate of Suitability (COS). The purpose of a Desmopressin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Desmopressin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Desmopressin to their clients by showing that a Desmopressin CEP has been issued for it. The manufacturer submits a Desmopressin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Desmopressin CEP holder for the record. Additionally, the data presented in the Desmopressin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Desmopressin DMF.
A Desmopressin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Desmopressin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Desmopressin suppliers with CEP (COS) on PharmaCompass.
A Desmopressin written confirmation (Desmopressin WC) is an official document issued by a regulatory agency to a Desmopressin manufacturer, verifying that the manufacturing facility of a Desmopressin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Desmopressin APIs or Desmopressin finished pharmaceutical products to another nation, regulatory agencies frequently require a Desmopressin WC (written confirmation) as part of the regulatory process.
click here to find a list of Desmopressin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Desmopressin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Desmopressin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Desmopressin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Desmopressin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Desmopressin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Desmopressin suppliers with NDC on PharmaCompass.
Desmopressin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Desmopressin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Desmopressin GMP manufacturer or Desmopressin GMP API supplier for your needs.
A Desmopressin CoA (Certificate of Analysis) is a formal document that attests to Desmopressin's compliance with Desmopressin specifications and serves as a tool for batch-level quality control.
Desmopressin CoA mostly includes findings from lab analyses of a specific batch. For each Desmopressin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Desmopressin may be tested according to a variety of international standards, such as European Pharmacopoeia (Desmopressin EP), Desmopressin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Desmopressin USP).
LOOKING FOR A SUPPLIER?